Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge

Eur Neuropsychopharmacol. 2015 Sep;25(9):1421-6. doi: 10.1016/j.euroneuro.2014.08.011. Epub 2014 Sep 1.

Abstract

The SNP rs167771 of the dopamine-3-receptor gene (DRD3) has been associated with autism spectrum disorder (ASD) in samples from the United Kingdom, The Netherlands and Spain. The DRD3 polymorphisms of rs167771 are significantly associated with a specific type of repetitive and stereotyped behavior, called sameness. Repetitive and stereotyped behavior occurs in several neuropsychiatric disorders and the combined picture across these disorders strongly suggests the involvement of the basal ganglia - frontal lobe circuitry. In autism, abnormalities of the basal ganglia, in particular the caudate nucleus, are the best replicated findings in neuroimaging studies. Interestingly, the DRD3 gene is highly expressed in the basal ganglia, most notably the caudate nucleus. The rs167771 SNP was recently also found to be related to risperidone-induced extra-pyramidal side effects (EPS) in patients with autism, which is important since risperidone is approved for the treatment of aggression, irritability and rigid behavior in ASD. To conclude, striatum abnormalities in autism are associated with repetitive and stereotyped behavior in autism and may be related to DRD3 polymorphisms.

Keywords: Autism; DRD3; Repetitive behavior; Review; Treatment.

Publication types

  • Review

MeSH terms

  • Autism Spectrum Disorder / drug therapy
  • Autism Spectrum Disorder / genetics
  • Autism Spectrum Disorder / physiopathology*
  • Basal Ganglia / physiopathology
  • Humans
  • Polymorphism, Genetic
  • Receptors, Dopamine D3 / genetics
  • Receptors, Dopamine D3 / metabolism*
  • Stereotyped Behavior / drug effects
  • Stereotyped Behavior / physiology*

Substances

  • DRD3 protein, human
  • Receptors, Dopamine D3